Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-493,850
Closed -$58.2M 130
2022
Q1
$58.2M Sell
493,850
-101,675
-17% -$7.24M 2.38% 4
2021
Q4
$47.1M Sell
595,525
-8,715
-1% -$729K 1.29% 11
2021
Q3
$47.7M Sell
604,240
-337,212
-36% -$27.1M 1.03% 10
2021
Q2
$74.2M Sell
941,452
-162,448
-15% -$12.4M 2.05% 7
2021
Q1
$83.2M Buy
1,103,900
+915,075
+485% +$67.1M 2.05% 6
2020
Q4
$12.4M Buy
+188,825
New +$11M 0.57% 46

Other funds holding ENOV

Islet Management's ENOV Position: Q2 2022 in Review

Islet Management sold out of Enovis (ENOV) in Q2 2022, closing a stake of 493,850 shares — an estimated $58.2M sold.

Islet Management first reported a position in ENOV in Q4 2020 and held it in 6 quarters. The position peaked at $83.2M in Q1 2021. 245 funds tracked by Wall St. Rank hold ENOV as of Q2 2022.

  • Islet Management reported no remaining Enovis position as of Q2 2022 after selling out during the quarter.
  • Islet Management sold 493,850 Enovis shares in Q2 2022, an estimated $58.2M.
  • Islet Management first reported a position in Enovis in Q4 2020 and held it in 6 quarters.
  • Islet Management's Enovis position peaked at $83.2M in Q1 2021.
  • 245 funds tracked by Wall St. Rank held Enovis as of Q2 2022.

Based on Islet Management's 13F filing for Q2 2022, filed 15 Aug 2022.